Half Year 2025 Genus PLC Earnings Call Transcript

Feb 27, 2025 / 08:30 AM GMT

Release Date Price: $22.5

Transcript

Key Points

Positve

Genus PLC (GENSF) achieved a 19% growth in adjusted operating profit to £45.2 million in actual currency.
The company signed new royalty contracts with three of the top five producers in China, indicating strong market penetration.
The FDA has accepted Genus PLC (GENSF)'s environmental assessment for PRP, with site inspections completed, paving the way for expected approval in 2025.
The Value Acceleration Program (VAP) is on track to deliver a £21 million run rate benefit by the end of the fiscal year.
Genus PLC (GENSF) reported strong cash flow improvements, with a significant reduction in working capital and biological asset outflows.

Negative

Currency fluctuations, particularly the strengthening of sterling, resulted in a £4.8 million adverse impact on profit translation.
The Chinese dairy market remains challenging, with a reported 9% contraction in production affecting ABS China performance.
Higher net financing costs due to increased interest rates and borrowings impacted financial results.
The company faces ongoing challenges in the Brazilian beef market, with weak demand for beef genetics.
Exceptional expenses, including restructuring costs and aborted corporate transactions, amounted to £6 million in the first half.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GNS.L - Genus PLC
Half Year 2025 Genus PLC Earnings Call
Feb 27, 2025 / 08:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone.

Thank you very much for joining us.

Here at Buchanan my name is Jurgen Koki, and I am Genus' CEO.

In this presentation, Allison Hendrickson, our CFO, and I will take you through Genus's interim results.

In summary, I would say that we have achieved strong financial results.

As well as significant strategic progress.

I'd like to take this opportunity to thank all of Genius's employees for their contributions in achieving these results.

Let me start with an overview of our an overview and our key financial headlines.

Here are my 3 strategic priorities which are unchanged.

Our first priority is continued growth in poor sign with more stable

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.